BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2014
View Archived Issues
Nihon Medi-Physics and Endocyte sign license agreement for companion diagnostic
Read More
Moderna launches new venture to focus on development of mRNA Therapeutics in oncology
Read More
Elixir Medical confirms first commercial implant of the DESolve scaffold system
Read More
Sanofi and Fraunhofer-Gesellschaft form natural product center of excellence for infectious diseases
Read More
Mass General, Broad Institute and Amgen form collaboration to treat IBD
Read More
IntegraGen enters collaboration to validate oncology biomarker
Read More
Resverlogix reports results from analysis of combined data from SUSTAIN and ASSURE trials
Read More
Patch under development by Taisho and Tokuhon shows efficacy in phase III trials in osteoarthritis
Read More
Tafinlar receives FDA breakthrough therapy designation for NSCLC with BRAF mutation
Read More
TS-734 shows promise as PET-imaging agent for early detection and treatment of Alzheimer's disease
Read More
Nab-paclitaxel shows promise in esophageal squamous cell carcinoma trial
Read More
Identification of a risk factor inversely correlated with cardiometabolic disease
Read More
Cytonet files MAA with EMA for use of liver cell therapy to treat urea cycle disorders in children
Read More
Japan Tobacco and Torii gain approval for Riona Tablets in Japan
Read More
Suglat tablets approved for treatment of type 2 diabetes in Japan
Read More
Xyzal syrup for allergic disease gains approval in Japan
Read More
SYK inhibitors revealed in Portola patents
Read More
Status updates provided for phase III METIV-HCC and ATTENTION trials of tivantinib
Read More
Metabotropic glutamate mGlu5 receptor PAMs reported in Vanderbilt University patent
Read More
Takeda obtains approval of Adcetris for treatment of malignant lymphoma in Japan
Read More
Merck & Co. researchers report discovery of SYK inhibitors
Read More
Torii's sublingual immunotherapy drug for Japanese cedar pollinosis approved in Japan
Read More
Japanese MHLW approves Bayer's Adempas for CTEPH
Read More
FDA committee votes against approval of rivaroxaban for ACS indication
Read More
